Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
RefinitivMeno di 1 minuto di lettura
Intellia Therapeutics Inc NTLA:
INTELLIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Accedi o crea un account gratuito per leggere queste notizie